Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results.
D000367:Age Factors; D000368:Aged; D000526:Alprenolol / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003325:Coronary Care Units; D003645:Death, Sudden; D005260:Female; D005500:Follow-Up Studies; D006334:Heart Function Tests; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D010919:Placebos; D012008:Recurrence; D013548:Sweden
D010919:Placebos; D000526:Alprenolol